SuperGen

Healthcare 📍 Dublin, United States 👥 51-200 employees 💰 $3.0M raised 📅 Founded 1991

SuperGen, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of therapies to treat patients with cancer. Products in Development MP-470â€”DNA Repair Suppressor: MP-470 is a multi-targeted Tyrosine Kinase Inhibitor that is specific for mutant forms of c-kit, PDGFRa, and FLT3. Th

🌐 Website ← All Companies

📊 Company Overview

Sector

Healthcare

Country

United States

Employees

51-200

Total Raised · Venture

$3.0M

Founded

1991

Cloud

Unknown

Email

Mimecast

☁️ Cloud Infrastructure

🔒 Subscribers only Cloud Provider

Workspace	Mimecast
CDN	🔒 Subscribers only

Detected via DNS records and HTTP response headers as of 2026-06-13.

💰 Estimated Cloud Spend

$450K – $1M / year across cloud providers

🛠 Tech Stack & Marketing

Ad Platforms	🔒 Subscribers only
Analytics & CRM	🔒 Subscribers only
CMS / Platform	🔒 Subscribers only
Frontend Stack	🔒 Subscribers only

Detected from SuperGen's public homepage as of 2026-06-13.

🔍 Compare with Similar Companies

Same sector (Healthcare), similar size

Mylan Specialty

201-500 ☁️ AWS

201-500 ☁️ Cloudflare

Park Hotels & Resorts

51-200 ☁️ Unknown

Data detected 2026-06-13 · Methodology · Suggest a correction